Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours

The aim of the current study was to evaluate the safety and the efficacy of radiofrequency thermal ablation (RFTA) for the treatment of nonsmall cell lung cancer (NSCLC) and isolated pulmonary metastases (METs) from colorectal cancer (CRC). A total of 31 patients (15 with NSCLCs and 16 with CRC lung METs), with 36 lung tumour nodules (mean±sd diameter: 22±8 mm, range: 10–35 mm) underwent computed tomography (CT)-guided RFTA using expandable electrodes. Contrast-enhanced CT was performed before and after (immediately and 30±5 days) each RFTA session to assess immediate results and complications and repeated 3 and 6 months post-RFTA, as well as every 6 months thereafter, to evaluate long-term results. Complete radiological necrosis was defined as a nonenhancing area at the tumour site that was equal to or larger than the treated tumour; persistence of enhancement at the tumour site indicated incomplete treatment. Local recurrence was defined as an increase in tumour size and/or enhancing tissue at the tumour site. Complete radiological necrosis of the 36 tumours was achieved with 39 RFTA sessions and 42 electrode insertions. No major complications or deaths were observed. Six patients experienced mild-to-moderate pain during the procedure. There were five cases of pneumothorax, none requiring drainage and four cases of pneumonia, which were successfully treated with antibiotics. After a mean follow-up of 11.4±7.7 months (range of 3–36 months), the overall local recurrence rate was 13.9% (20 and 9.5% for NSCLC and CRC-METs patients, repectively). Nineteen of the 31 (61.3%) patients were alive (15 apparently disease free) and 12 (38.7%) had died (three from causes unrelated to their cancer). Radiofrequency thermal ablation seems to be a safe, effective method for producing complete ablation of small nonsmall cell lung cancers and pulmonary colorectal cancer metastases.

[1]  E. Patterson,et al.  Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size. , 1998, Annals of surgery.

[2]  H. Kinoshita,et al.  Percutaneous radiofrequency ablation of lung neoplasms: a minimally invasive strategy for inoperable patients. , 2002, Journal of the American College of Surgeons.

[3]  F. Garbagnati,et al.  Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. , 1998, AJR. American journal of roentgenology.

[4]  B. Yalcin,et al.  Multidisciplinary management of lung cancer. , 2004, The New England journal of medicine.

[5]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[6]  G. Silvestri,et al.  What happens to patients undergoing lung cancer surgery? Outcomes and quality of life before and after surgery. , 2002, Chest.

[7]  Young Min Han,et al.  Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. , 2004, Radiology.

[8]  J. Goldin,et al.  Unresectable pulmonary malignancies: CT-guided percutaneous radiofrequency ablation--preliminary results. , 2003, Radiology.

[9]  L. Ellis,et al.  Radiofrequency Ablation of Unresectable Primary and Metastatic Hepatic Malignancies: Results in 123 Patients , 1999 .

[10]  H. Präuer,et al.  Factors influencing survival after resection of pulmonary metastases from colorectal cancer , 2004, The British journal of surgery.

[11]  H. Kinoshita,et al.  Percutaneous radiofrequency ablation of lung neoplasms: a minimally invasive strategy for inoperable patients. , 2002, Journal of the American College of Surgeons.

[12]  L Solbiati,et al.  Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. , 1999, Radiology.

[13]  R. Fietkau.  Stage-III NSClC: multimodality therapy for inoperable tumours. , 2004, Lung cancer.

[14]  G. Colucci,et al.  Radiofrequency ablation of 40 lung neoplasms: preliminary results. , 2004, AJR. American journal of roentgenology.

[15]  C. Mountain,et al.  Regional lymph node classification for lung cancer staging. , 1997, Chest.

[16]  L. Organ.  Electrophysiologic principles of radiofrequency lesion making. , 1976, Applied neurophysiology.

[17]  S. Rose,et al.  Cerebral microembolization during radiofrequency ablation of lung malignancies. , 2002, Journal of vascular and interventional radiology : JVIR.

[18]  J. Tschopp,et al.  Risk factors for early mortality and major complications following pneumonectomy for non-small cell carcinoma of the lung. , 2002, Chest.

[19]  W W Mayo-Smith,et al.  Percutaneous radiofrequency ablation of malignancies in the lung. , 2000, AJR. American journal of roentgenology.

[20]  G. Gazelle,et al.  Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection , 2003, Cancer.

[21]  G Marchal,et al.  Radiofrequency ablation for eradication of pulmonary tumor in rabbits. , 2001, The Journal of surgical research.

[22]  L Solbiati,et al.  Hepatic metastases: percutaneous radio-frequency ablation with cooled-tip electrodes. , 1997, Radiology.

[23]  A Marasso,et al.  Radiofrequency resection of bronchial tumours in combination with cryotherapy: evaluation of a new technique. , 1998, Thorax.

[24]  S. Spiro,et al.  Lung cancer--where are we today? Current advances in staging and nonsurgical treatment. , 2002, American journal of respiratory and critical care medicine.

[25]  P. Scanlon.  Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. , 1994, Chest.

[26]  B. Nordlinger,et al.  Colorectal metastasis (liver and lung). , 2002, The Surgical clinics of North America.

[27]  M. Fattorutto.  Massive hemorrhage during radiofrequency ablation of a pulmonary neoplasm. , 2003, Anesthesia and analgesia.

[28]  G. Mychaskiw,et al.  Massive hemorrhage during radiofrequency ablation of a pulmonary neoplasm. , 2002, Anesthesia and analgesia.

[29]  C Bartolozzi,et al.  Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. , 2000, Radiology.

[30]  G. Casola,et al.  CT-guided transthoracic needle biopsy , 2007, CardioVascular and Interventional Radiology.

[31]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary. , 2001, Respiratory care.

[32]  S. Mulier,et al.  Size and geometry of hepatic radiofrequency lesions. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.